These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28413689)

  • 1. L1000CDS
    Duan Q; Reid SP; Clark NR; Wang Z; Fernandez NF; Rouillard AD; Readhead B; Tritsch SR; Hodos R; Hafner M; Niepel M; Sorger PK; Dudley JT; Bavari S; Panchal RG; Ma'ayan A
    NPJ Syst Biol Appl; 2016; 2():16015-. PubMed ID: 28413689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy.
    Lee JY; Gallo RA; Ledon PJ; Tao W; Tse DT; Pelaez D; Wester ST
    Transl Vis Sci Technol; 2020 Aug; 9(9):39. PubMed ID: 32908802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures.
    Duan Q; Flynn C; Niepel M; Hafner M; Muhlich JL; Fernandez NF; Rouillard AD; Tan CM; Chen EY; Golub TR; Sorger PK; Subramanian A; Ma'ayan A
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W449-60. PubMed ID: 24906883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound signature detection on LINCS L1000 big data.
    Liu C; Su J; Yang F; Wei K; Ma J; Zhou X
    Mol Biosyst; 2015 Mar; 11(3):714-22. PubMed ID: 25609570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules.
    Kropiwnicki E; Lachmann A; Clarke DJB; Xie Z; Jagodnik KM; Ma'ayan A
    BMC Bioinformatics; 2022 Feb; 23(1):76. PubMed ID: 35183110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository.
    Musa A; Tripathi S; Dehmer M; Emmert-Streib F
    Front Genet; 2019; 10():557. PubMed ID: 31258549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SigCom LINCS: data and metadata search engine for a million gene expression signatures.
    Evangelista JE; Clarke DJB; Xie Z; Lachmann A; Jeon M; Chen K; Jagodnik KM; Jenkins SL; Kuleshov MV; Wojciechowicz ML; Schürer SC; Medvedovic M; Ma'ayan A
    Nucleic Acids Res; 2022 Jul; 50(W1):W697-W709. PubMed ID: 35524556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating Differential Gene Expression Analysis with Predictive Biomarkers to Identify Novel Therapeutic Drugs for Fuchs Endothelial Corneal Dystrophy.
    Wen H; Gallo RA; Huang X; Cai J; Mei S; Farooqi AA; Zhao J; Tao W
    J Ophthalmol; 2021; 2021():5580595. PubMed ID: 34258047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting Started with LINCS Datasets and Tools.
    Xie Z; Kropiwnicki E; Wojciechowicz ML; Jagodnik KM; Shu I; Bailey A; Clarke DJB; Jeon M; Evangelista JE; V Kuleshov M; Lachmann A; Parigi AA; Sanchez JM; Jenkins SL; Ma'ayan A
    Curr Protoc; 2022 Jul; 2(7):e487. PubMed ID: 35876555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach to accurate and robust signature detection on LINCS L1000 data.
    Qiu Y; Lu T; Lim H; Xie L
    Bioinformatics; 2020 May; 36(9):2787-2795. PubMed ID: 32003771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Signature Detection Based on L1000 Genomic and Proteomic Big Data.
    Chen W; Zhou X
    Methods Mol Biol; 2019; 1939():273-286. PubMed ID: 30848467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming L1000 profiles to RNA-seq-like profiles with deep learning.
    Jeon M; Xie Z; Evangelista JE; Wojciechowicz ML; Clarke DJB; Ma'ayan A
    BMC Bioinformatics; 2022 Sep; 23(1):374. PubMed ID: 36100892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced adverse events prediction with the LINCS L1000 data.
    Wang Z; Clark NR; Ma'ayan A
    Bioinformatics; 2016 Aug; 32(15):2338-45. PubMed ID: 27153606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent.
    Han HW; Hahn S; Jeong HY; Jee JH; Nam MO; Kim HK; Lee DH; Lee SY; Choi DK; Yu JH; Min SH; Yoo J
    Sci Rep; 2018 Oct; 8(1):14969. PubMed ID: 30297806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics.
    Pushparaj PN; Abdulkareem AA; Naseer MI
    Front Pharmacol; 2021; 12():688227. PubMed ID: 34531741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Quality Control Analysis of LINCS Data.
    Cheng L; Li L
    CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):588-598. PubMed ID: 27796074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Effect Prediction by Integrating L1000 Genomic and Proteomic Big Data.
    Chen W; Zhou X
    Methods Mol Biol; 2019; 1939():287-297. PubMed ID: 30848468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l1kdeconv: an R package for peak calling analysis with LINCS L1000 data.
    Li Z; Li J; Yu P
    BMC Bioinformatics; 2017 Jul; 18(1):356. PubMed ID: 28750623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1000FWD: fireworks visualization of drug-induced transcriptomic signatures.
    Wang Z; Lachmann A; Keenan AB; Ma'ayan A
    Bioinformatics; 2018 Jun; 34(12):2150-2152. PubMed ID: 29420694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data.
    De Wolf H; De Bondt A; Turner H; Göhlmann HW
    Assay Drug Dev Technol; 2016 May; 14(4):252-60. PubMed ID: 27187605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.